Clinical practice guidelines for duodenal cancer 2021.
Clinical practice guidelines for duodenal cancer 2021.
复制标题
DOI：
10.1007/s00535-022-01919-y
复制
发表时间：
2022-12
影响因子：
6.3
通讯作者：
Kodera, Yasuhiro
中科院分区：
文献类型：
--
作者：
Nakagawa, Kenji;Sho, Masayuki;Fujishiro, Mitsuhiro;Kakushima, Naomi;Horimatsu, Takahiro;Okada, Ken-ichi;Iguchi, Mikitaka;Uraoka, Toshio;Kato, Motohiko;Yamamoto, Yorimasa;Aoyama, Toru;Akahori, Takahiro;Eguchi, Hidetoshi;Kanaji, Shingo;Kanetaka, Kengo;Kuroda, Shinji;Nagakawa, Yuichi;Nunobe, Souya;Higuchi, Ryota;Fujii, Tsutomu;Yamashita, Hiroharu;Yamada, Suguru;Narita, Yukiya;Honma, Yoshitaka;Muro, Kei;Ushiku, Tetsuo;Ejima, Yasuo;Yamaue, Hiroki;Kodera, Yasuhiro
关键词：
十二指肠癌在临床病理学上被认为是一种小肠癌。在日本，没有基于充分科学证据的既定治疗指南;因此，在日常临床实践中，治疗基于个体医生的经验。然而，随着诊断方式的进步，预计未来发现的机会将增加。我们制定了十二指肠癌指南，因为这种疾病被认为是医疗保健提供者和患者对适当管理的高度医疗需求。制定这些指南是为了在实际临床实践中用于怀疑患有非壶腹十二指肠上皮恶性肿瘤的患者和诊断患有非壶腹十二指肠上皮恶性肿瘤的患者。在这项研究中，根据Minds Practice Guideline Development Manual 2017开发了一个实践算法，并为流行病学和诊断，内窥镜治疗，手术治疗和化疗的每个领域设置了临床问题。通过文献检索和系统审查拟定了一份建议草案，随后对建议进行了表决。我们根据实际的临床实践做出决定，因此证据水平不会是建议的唯一决定因素。本指南是截至编写时最标准的指南。在决定如何处理每一个病例时，必须与患者及其家属、主治医生和其他医务人员协商，考虑到设施的实际情况（和患者的特征）。
Duodenal cancer is considered to be a small intestinal carcinoma in terms of clinicopathology. In Japan, there are no established treatment guidelines based on sufficient scientific evidence; therefore, in daily clinical practice, treatment is based on the experience of individual physicians. However, with advances in diagnostic modalities, it is anticipated that opportunities for its detection will increase in future. We developed guidelines for duodenal cancer because this disease is considered to have a high medical need from both healthcare providers and patients for appropriate management. These guidelines were developed for use in actual clinical practice for patients suspected of having non-ampullary duodenal epithelial malignancy and for patients diagnosed with non-ampullary duodenal epithelial malignancy. In this study, a practice algorithm was developed in accordance with the Minds Practice Guideline Development Manual 2017, and Clinical Questions were set for each area of epidemiology and diagnosis, endoscopic treatment, surgical treatment, and chemotherapy. A draft recommendation was developed through a literature search and systematic review, followed by a vote on the recommendations. We made decisions based on actual clinical practice such that the level of evidence would not be the sole determinant of the recommendation. This guideline is the most standard guideline as of the time of preparation. It is important to decide how to handle each case in consultation with patients and their family, the treating physician, and other medical personnel, considering the actual situation at the facility (and the characteristics of the patient).
登录
查看更多内容
影响因子：
3.9
作者：
Duerr D;Ellard S;Zhai Y;Taylor M;Rao S
通讯作者：
Rao S
影响因子：
--
作者：
Bakaeen, FG;Murr, MM;Donohue, JH
通讯作者：
Donohue, JH
影响因子：
7.3
作者：
Breuhahn, K.;Singh, S.;Blaeker, H.
通讯作者：
Blaeker, H.
影响因子：
3.7
作者：
Cloyd, Jordan M.;Norton, Jeffrey A.;Poultsides, George A.
通讯作者：
Poultsides, George A.
影响因子：
5.3
作者：
Goda, Kenichi;Kikuchi, Daisuke;Abe, Noritsugu
通讯作者：
Abe, Noritsugu